Trademarkia Logo

Canada

C$
Trademark Search in Canada
ALMOND THERAPY: TARGETING THE AMYGDALA

View On IC.GC.CA

ALMOND THERAPY: TARGETING THE AMYGDALA
FORMALIZED

on 3 Dec 2021

Last Applicant/ Owned by

PSILOTEC HEALTH SOLUTIONS INC.

855 2nd Street S.W., Suite 3500Calgary

ALBERTA

CA

T2P4J8

Serial Number

2151723 filed on 3rd Dec 2021

Correspondent Address

BLAKE, CASSELS & GRAYDON LLP

INTELLECTUAL PROPERTY GROUPSUITE 4000, COMMERCE COURT WEST199 BAY STREETTORONTO

ONTARIO

CA

M5L1A9

ALMOND THERAPY: TARGETING THE AMYGDALA

Trademark usage description

compilation and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical tr Read More

Classification Information

Class [035]
Compilation and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification kind code

11

Class [041]
Provision of education and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education and training in the field of psychedelic medicines

Classification kind code

11

Class [042]
Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; non-downloadable computer software for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification kind code

11

Class [044]
Psychotherapy services; therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services

Classification kind code

11

Mark Details

Serial Number

2151723

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 287
on 12th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 3rd Dec 2021		Filed
Submitted for opposition 1
on 3rd Dec 2021		Created
Submitted for opposition 31
on 3rd Dec 2021		Formalized